Skip to main content

Table 1 Chemotherapy medicine availability in South Africa per healthcare sector.

From: Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa

Healthcare Sector Guideline chemotherapy selection Medicines available
Public Department of Health Master Procurement Catalogue (EML and STG) 5-FU (+LV), Capecitabine, Oxaliplatin, aIrinotecan
Private Various medical aid scheme formularies for the South African Health Products Regulatory Authority (previously Medicines Control Council) approved medicines 5-FU (+LV), Capecitabine, Oxaliplatin, Irinotecan, Bevacizumab, Cetuximab,
bPanitumumab, cAflibercept, bRegorafenib
  1. a Subsequent to this study has been approved for use in the public sector. Medicines underlined are available in both healthcare sectors.
  2. bSubsequent to this study Panitumumab and Regorafenib have been approved for use by SAHPRA - South African Health Products Regulatory Authority – but was previously available through a Section 21named patient use application.
  3. cNot yet registered for use in South Africa but is available through Section 21 named patient application.